Article
Precision survival estimation in acute myeloid leukemia using evolutionary learning-derived microRNA signature
2026-05-26
Abstract excerpt
<h4>Background</h4> Acute myeloid leukemia (AML) remains the most lethal acute leukemia in adults, with 5-year overall survival below 32% despite recent advances including venetoclax-, FLT3-, IDH1/2-, and Menin-targeted therapies. Clinical outcomes remain highly heterogeneous across patients, highlighting the need for robust molecular biomarkers capable of improving prognostic precision. MicroRNAs (miRNAs) are cr...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8fdf7464-a6d7-5453-b615-9d576f849f6b
- DOI
- 10.64898/2026.05.22.727196
